T1	Premise 1209 1278	Anemia was the most common hematological toxicity (88 % of patients).
T2	Premise 1279 1382	Most frequent non-hematological toxicities were nausea (76 %), constipation (68 %), and fatigue (64 %).
T3	Claim 1383 1523	Treatment was generally well tolerated despite the fact that most patients suffered from multiple comorbidities and were heavily pretreated.
T4	Claim 1524 1595	There were no unexpected hematological or non-hematological toxicities.
R1	Support Arg1:T1 Arg2:T4	
R2	Support Arg1:T2 Arg2:T4	
R3	Support Arg1:T4 Arg2:T3	
